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Rheumatic fever (RF) is currently the most important cause of
acquired heart disease among children in South Africa.1 A 2002
report from a paediatric cardiology workshop highlights the
belief among clinicians that South Africa is currently in the
midst of a RF epidemic.2 While accurate epidemiological data
are urgently needed to confirm this suspicion, efforts to
address the situation have already been launched.  In 1997, the
South African Department of Health (DOH) released a set of
national guidelines on the primary prevention and prophylaxis
of rheumatic fever (RF) and rheumatic heart disease (RHD).3
The guidelines were intended to facilitate a comprehensive
programme for the primary and secondary prevention of RF.
Targeting health workers at the primary care level, they cover
interventions addressing education, living conditions,
diagnosis, treatment, referral, notification, and follow-up.  
While these guidelines are comprehensive and evidence-
based,4,5 it is not clear what impact they have had on clinical
practice or on the overall burden of disease associated with RF
and RHD.  The purpose of this study was to explore the extent
to which current practices for the secondary prevention of RF
at the primary level adhere to those outlined in the national
guidelines.
Methods
This study used various methodologies, primarily qualitative,
to assess the extent to which the objective of implementing a
comprehensive programme for the secondary prevention of
RF/RHD has been achieved in the Cape metropole area.  The
evaluation focused on a set of four priority issues identified in
the 1997 national guidelines. These priority issues include: 
(i) health education and promotion; (ii) case detection of RF
and RHD; (iii) secondary prophylaxis every 3 - 4 weeks
(referral back to primary level); and (iv) notification of acute
rheumatic fever (ARF).3 We obtained data from several
sources:  case/guardian interviews, physician questionnaires,
and statistics on disease notification from hospital,
metropolitan, and provincial records. The University of Cape
Town Research Ethics Committee approved the study.
For priority issues 1, 2, and 3 (health education/promotion,
case detection, and secondary prophylaxis) we conducted a
retrospective qualitative case study of children aged 3 - 12
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years, who had been diagnosed with ARF during the period
1999 - 2003. We identified cases from Red Cross Children’s
Hospital (RXH) using two discrete search techniques: a manual
search of records from the RXH rheumatic fever clinic and an
electronic search of the hospital’s diagnosis database.  We
screened the medical records and applied the Jones criteria to
include only definite cases of RF.6 We then extracted relevant
biographical and medical history data using a data extraction
form.
Through a community health worker, we contacted the
caregivers of all included cases (N = 8) to arrange face-to-face
interviews.  The interviews were semi-structured, lasted
approximately 20 minutes, and focused on the delivery of care
at the time of diagnosis, adherence to secondary prophylaxis,
and general knowledge of the causes and effects of RF/RHD.
A single investigator (KAR) conducted the interviews in
English and each interviewee was given the opportunity to ask
questions about RF/RHD.  We used a Xhosa translator when
required.
A second data source for the evaluation of priority issues 1, 3
and 4 (health education/promotion, secondary prophylaxis,
and RF notification) was a self-administered, structured
physician questionnaire. Initially the evaluation was planned to
target physicians working at the primary level, given that the
national guidelines specifically target that level.  However,
patient/guardian interviews revealed that patients had little
interaction with health care professionals at the primary level
during visits for prophylactic treatment.  Therefore, a broader
sample of physicians was required, consisting of three groups:
one from Groote Schuur Hospital (GSH), one from RXH, and a
group of private general practitioners (GPs) from the Cape
Town area.  The group from GHS was a convenience sample of
physicians working in areas most likely to encounter a case of
RF (i.e. the emergency unit and the cardiac clinic in the
Department of Medicine).  The group from RXH was a
convenience sample of physicians from the medical outpatient
department.  The group of private GPs was a non-random
sample of physicians known to one of the investigators (BMM).
All participating physicians were selected on the basis of their
willingness to participate in the survey. The physician
questionnaire focused on awareness of and adherence to the
national guidelines (Appendix A).
Additional data for the evaluation of priority issue 4 (RF
notification) were obtained through a review of hospital, city,
and provincial records on disease notification.  We reviewed
records from RXH for notification statistics from 1999 to 2003
and obtained official government statistics from health
information specialists at city and provincial level.  Case
information available from all sources included the date of
diagnosis and the residential address at the time of diagnosis.
We analysed our findings by summarising the information
gathered from the various sources, using these summaries as
the basis for evaluation of the four priority issues.  Responses
obtained through the case/guardian interviews and the
physician questionnaires contained primarily factual
information that could be summarised easily; therefore the
investigators felt that a formal coding system of analysis was
unnecessary.  For the analysis of disease notification, we
compared the number of cases reported from each level and
cross-referenced each case based on the individual’s address.
Results
We identified 67 possible cases of ARF from the search of
RXH’s records.  After reviewing the medical records and
applying the Jones criteria, we excluded 54 cases and selected
13 cases for follow-up.  The majority of excluded cases were
either chronic RF/RHD cases that had visited RXH within the
past 5 years or cases that did not fulfill the diagnostic criteria.
Of the 13 cases selected, we were able to locate and interview 8
cases.
A total of 24 physicians responded to the questionnaire.
Twelve physicians from GSH participated in the study, 5
medical registrars and 7 senior house officers.  Eight physicians
participated from RXH, all of whom were physicians working
in the medical outpatient department.  Five private GPs were
contacted to participate, 4 of whom responded to the
questionnaire.  
Health education and training of all personnel
involved with children
Information gathered through the case/guardian interviews
revealed high levels of ignorance concerning all aspects of the
disease. Six of the 8 guardians said that they did not know
what causes RF, 1 stated that it was caused by ‘something in
the air’, and one stated that it was caused by a sore throat.
None could explain how to prevent it, and none knew the
purpose of the monthly injections.  Seven of the 8 guardians
had not heard of RF before the child’s diagnosis, and the same
number had not heard of the disease from any source other
than the doctor.  One parent claimed to have heard it
mentioned on the radio.
The physician survey yielded conflicting results regarding
awareness among physicians of the existence of the national
guidelines.  Seven of the 12 physicians sampled from GSH and
2 of the 4 private GPs were aware of the guidelines.  None of
the physicians sampled at RXH, the location most likely to see
cases of ARF, was aware of the guidelines.  Inquiry into the
type of information provided to the patient and guardian at the
time of diagnosis indicated that physicians from all groups
stress the importance of adherence to prophylaxis.  Many also
commented on the causes, basic pathophysiology, and long-
term consequences of the disease.
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Case detection of ARF 
The guidelines do not state clearly how increased detection of
ARF will be achieved. Specifically, the guideline does not
stipulate whether new cases or recurrent attacks should be
notified, and the level of diagnostic certainty required before
notification. The Jones criteria for the diagnosis of RF apply to
the first attack, and recurrences may be diagnosed without
meeting all the criteria. The lack of clarity of the guideline on
the method of case detection may contribute to the lack of
effectiveness of the current notification system for RF.
Secondary prophylaxis (with referral back to
primary level)
Information used for the evaluation of this priority issue was
gathered through the case/guardian interviews and physician
questionnaires.  The findings from the interviews suggest high
levels of adherence to secondary prophylaxis, with 7 of 8 cases
claiming that they have not missed a treatment.  One patient,
diagnosed in 2001, had not received any treatment for the past
year.  Six of the 7 cases reporting adherence received monthly
treatments at primary care level (community health clinics)
while 1 received all treatment at the RF clinic at RXH.  Those
receiving treatment at primary care level reported little or no
discussion of their condition with health care personnel at the
time of treatment.  Six cases received treatment in the form of
monthly intramuscular injections of penicillin, while 1 case
received penicillin orally because of the pain of injection.  Six of
the 7 cases receiving treatment in the primary care setting also
attended follow-up visits at the RF clinic every 3 - 6 months. 
Notification of RF
RF is a notifiable disease in South Africa (Health Act No. 63 of
1977).  Legally, the responsibility for case notification falls on
the ‘first health care professional or facility with whom a
patient presenting with [rheumatic fever] comes into contact’.7
We evaluated the notification system for RF based on
information derived from physician questionnaires, as well as
incidence data collected at hospital, city and provincial level.
Results from the physician survey and conflicting disease
statistics found at various administrative levels indicate that
the current notification system has not been implemented
effectively and is not accurately capturing the burden of
disease attributable to RF.
The physician survey revealed wide discrepancies in RF
notification practices. Only five of the 12 physicians from GSH
and 2 of the 4 private GPs said that they either notify cases of
ARF or would if presented with one.  Only 1 of the 8
physicians sampled from RXH reported notifying cases.  
Table I gives a summary of the number of notifications for
new cases of RF in the Cape metropole region during the
period from 1999 to 2003 according to various sources.
Records on reportable diseases from RXH indicate that the
hospital has notified the local health authorities of 39 new RF
cases during this period, all with addresses within the
metropolitan area.  A review of these cases conducted by the
investigator (KAR) found that 1 of these cases had been
reported twice.   There is currently no system in place at
hospital or government level to identify double reporting.
Data from the City of Cape Town’s Department of Health and
the Provincial Authorities of the Western Cape indicate that 17
and 28 cases of RF, respectively, were reported within the
metropolitan area during the same period.  
A further review of the records showed that of the 8 ARF
cases identified for interview purposes, 6 were diagnosed at
RXH.  Of those 6, 3 were notified according to both hospital
and city records.  With regard to the non-RXH cases, 1 case was
diagnosed at Tygerberg Hospital and was reported to health
authorities, and the other was diagnosed at Eben Donges
Hospital and was not reported to the health authorities.
Therefore, according to the cohort of cases interviewed, the
health department’s reporting system identified only half the
cases of ARF within the 5-year period.
Discussion
This study revealed that little progress has been made towards
establishing a comprehensive secondary prophylaxis
programme for RF in Cape Town since the publication of the
national guidelines in 1997.  Given the shortcomings of the
current RF notification system in South Africa, it is not feasible
to obtain a reliable estimate of the impact of the national
guidelines on disease incidence.  However, the evaluation
revealed four key findings that merit discussion.  First, patient
knowledge on the disease is almost non-existent. Yet despite
this lack of knowledge, adherence to secondary prophylactic
treatment was good.  Second, physician awareness and
compliance with the national guideline was unsatisfactory.
Third, the method for case detection of RF was unclear. And
finally, the RF notification system was dysfunctional.  
The first key finding suggests that individuals most affected
by RF and RHD know little about the disease, including
methods for prevention and the potential long-term
consequences.  However the question-and-answer sessions
held at the end of each interview frequently resulted in the
guardian recalling one physician’s explanation of the disease
given at the time of the child’s diagnosis.  The inability of
patients and guardians to retain the information provided at
Table I. Discrepancies in statistics on ARF cases in the Cape
metropolitan area from 1999 to 2003 (N)
Red Cross Children’s Hospital Municipal Provincial
reportable disease database health authority health authority
39 17 28
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the time of diagnosis could be attributable to the complexity
and sheer volume of information needed to understand the
illness.  Our study therefore highlights the need for more
effective methods for communicating knowledge to patients.
The fact that 7 of the 8 cases interviewed had not heard of RF
before diagnosis also suggests a low level of community
awareness of the disease.  Implementation of targeted health
promotion programmes for RF/RHD (a priority issue
identified by the national guideline), aimed at improving
patient and community knowledge of the disease is therefore
urgently needed.
Despite lack of patient understanding/knowledge of the
disease and the specific benefits of treatment, adherence to
prophylactic treatment was high. This finding does not fit the
traditional ‘knowledge, attitudes, practice’ (KAP) model8 of
health promotion, founded on the premise that knowledge is
required for individuals to change their behaviour.  Other
determinants of adherence may therefore be in operation in
this setting and warrant exploration in future studies.
Our second major finding was that physicians most likely to
encounter RF are not aware that it is a notifiable disease.  To
address this shortcoming, appropriate education and increased
use of physician reminders for the requirement of notification
are needed.
Our third finding highlights the failure of the guideline to
address the issue of case detection adequately.  The national
guideline does not include strategic objectives for improving
incident case detection, nor does it address procedures for
detection and notification of recurrent RF cases. It also fails to
address the issue of case detection for subclinical group A β-
haemolytic streptococcus infection and its impact on the
burden of RF/RHD.
The inconsistent data reports on RF incidence over the past 5
years at hospital, municipal and provincial levels leads to our
last finding, namely that the current RF notification system is
inaccurate and unreliable.  Only 4 of the 8 cases that we
interviewed had been reported to the health authorities.
According to reports from the national Department of Health,
there were only 7 and 11 notified cases of RF and no deaths
attributed to RF in 2002 and 2003, respectively.7 This is likely to
be a gross underestimate of the incidence of RF in South Africa,
and suggests that the findings of our study are likely to be
generalisable to the rest of the country. Efforts are needed to
address the current problems which appear to be both
endogenous (problems with the actual system of reporting)
and exogenous (failure to implement the system properly).  
Some of the systemic problems in the notification system
deserve special mention.  From the point at which a suspected
case first enters the health system (usually at primary care
level), to the time the patient is diagnosed with RF (usually at a
tertiary care centre), he or she has been seen by several health
care professionals.  The legal obligation of reporting currently
falls on the first health care professional to come into contact
with the patient.  This obligation seems misplaced in the case
of RF as it would be preferable for the physician who is
ultimately responsible for the diagnosis to assume
responsibility.  The system has been modified to correct for
these shortcomings, evident through the observed reporting
activity currently taking place at RXH. However,
misconceptions among health care professionals on their legal
responsibility to notify are still widespread.
This evaluation of the national guidelines on the primary
prevention and prophylaxis of RF and RHD for health
professions at primary level was not intended to be a
comprehensive review. We conducted a preliminary assessment
of the progress made in priority areas identified by the
guidelines as central to the establishment of a comprehensive
programme for secondary prevention of RF/RHD.   Our
review suffers from several potential shortcomings. The
guidelines were designed to target health care professionals
working at primary care level whereas most of the physicians
who participated in the survey were practising at tertiary level.
Assessing awareness and compliance levels at primary care
level is especially important for evaluating the level of case
detection and the effectiveness of the primary prevention
system. An additional weakness of this study is the potential
for bias introduced by our inability to obtain a random sample
of physicians to participate in the survey.    Lack of rando-
misation could result in either an over- or underestimation of
physician awareness of RF/RHD guidelines and protocols.
Conclusion
Our findings show that since the publication of the guidelines
in 1997, little progress has been made towards achieving the
implementation of a comprehensive programme for the
secondary prevention of RF/RHD.  Patient knowledge of
RF/RHD is virtually non-existent; however, adherence to
prophylactic therapy seems high, presenting a scenario that
appears to contradict traditional models of health promotion
and behaviour change.  Physician knowledge and compliance
with the guidelines is inconsistent. In addition, the guidelines
do not clearly state how increased detection of ARF will be
achieved. Finally, the notification system for RF is currently
dysfunctional and probably does not provide an accurate
depiction of the current burden of disease associated with RF
in the Cape metropole area.  The implementation of an
effective notification system for RF is paramount to the health
system’s ability to assess the current burden of disease
attributable to RF/RHD, and to monitor future progress
towards reducing that burden.
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Appendix A. Summary of physician questionnaire
Affiliated hospital (circle one) RXH GSH Tygerberg
Department OR    Location of private practice
1. Are you aware of the existence of national guidelines on the primary prevention and prophylaxis of RF/RHD for physicians at
the primary level? (If NO, skip to question 5)
2. When did you first become familiar with the guidelines?
3. Do you follow the clinical guidelines when diagnosing and treating cases of acute RF?
4. Do you believe these guidelines provide appropriate measures for the secondary prevention of RF/RHD? If not, why?
5. What information do you typically provide the patient/caregiver on RF at the time of diagnosis?
6. Do you believe the distribution of an informational pamphlet on RF/RHD at the time of diagnosis would be a useful tool for
raising patient awareness of the disease?
7. Do you report cases of acute RF to the local health authorities?
8. Approximately how many cases of ARF have you diagnosed in the last year?
